Seeking Alpha

Teva Pharmaceutical (TEVA +2.3%) shrugs off a downgrade to Hold at Canaccord to trade higher...

Teva Pharmaceutical (TEVA +2.3%) shrugs off a downgrade to Hold at Canaccord to trade higher today. The company has been creeping higher since posting a less-than-stellar Q4 earnings report yesterday morning, perhaps in part due to comments during its conference call that sales of its MS drug Copaxone rose by 14% to $1.1B. Read more here: Earnings Call Transcript.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)